Solid epithelial tumor
Item
diagnosis of solid epithelial tumor, including, but not limited to, the following:
boolean
C0280100 (UMLS CUI [1,1])
C1368683 (UMLS CUI [1,2])
Breast cancer
Item
breast cancer
boolean
C0678222 (UMLS CUI [1])
Ovarian cancer
Item
ovarian cancer
boolean
C0029925 (UMLS CUI [1])
Lung cancer
Item
lung cancer
boolean
C0242379 (UMLS CUI [1])
Uterine cancer
Item
uterine cancer
boolean
C0153567 (UMLS CUI [1])
Prostate cancer
Item
prostate cancer
boolean
C0600139 (UMLS CUI [1])
her2/neu status by immunohistochemistry or fluorescent in situ hybridization
Item
her2/neu-positive disease by immunohistochemistry or fluorescent in situ hybridization
boolean
C0242957 (UMLS CUI [1,1])
C0021044 (UMLS CUI [1,2])
C0162789 (UMLS CUI [1,3])
trastuzumab and/or chemotherapy
Item
must be receiving trastuzumab (herceptin®) and/or chemotherapy (e.g., paclitaxel, docetaxel, fluorouracil, or estramustine)
boolean
C0728747 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
Patient characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Absolute Neutrophil Count
Item
absolute neutrophil count > 1,000/mm^3
boolean
C0948762 (UMLS CUI [1])
Absolute Lymphocyte Count
Item
absolute lymphocyte count > 400/mm^3
boolean
C3544087 (UMLS CUI [1])
Platelet Count
Item
platelet count > 90,000/mm^3
boolean
C0032181 (UMLS CUI [1])
Hemoglobin
Item
hemoglobin > 8 g/dl
boolean
C0518015 (UMLS CUI [1])
concurrent therapy
Item
prior concurrent therapy:
boolean
C0009429 (UMLS CUI [1])
Chemotherapy
Item
no other chemotherapy within the past 4 weeks
boolean
C0392920 (UMLS CUI [1])